Dr Sheridan A. Gho
Founder and CEO, Cenofex Innovations
Dr Gho holds a PhD in Biomechanics as well as a Bachelor of Science with Class 1 Honours, and a Graduate Certificate in Research Commercialisation. She also graduated with distinction from the NSW Medical Device Commercialisation Training Program (2014), following which she was awarded the 2015-2017 NSW Health-Rosenman Institute Fellowship. This Fellowship placed her at the University of California, in San Francisco for two years where she co-founded and developed Cenofex Innovations, a medical device company revolutionising the management of lymphoedema. With over eleven years’ experience in biomechanics, social, and health research, and extensive medical device commercialisation training, Dr Gho is the company lead in clinical research, stakeholder relations, managing intellectual property, and regulatory affairs. Since returning to Australia in 2018, Cenofex Innovations has been awarded Regulatory Strategy and Intellectual Property prizes, and secured $1.5 Million from the NSW Medical Devices Fund.
Dr Gho is also an Honorary Research Fellow at the Illawarra Health and Medical Research Institute (University of Wollongong), and continues to collaborate with the academic community.